The FDA approved AbbVie’s (ABBV.N) tavapadon-branded Juvmo-for adult Parkinson’s disease on Friday, validating the drugmaker’s $8.7 billion Cerevel Therapeutics acquisition and opening a market analysts peg at more than $5 billion in combined Parkinson’s...
U.S. stock futures slipped Sunday evening after President Trump rejected a proposed nuclear deal with Iran, keeping military options open and injecting...
Honda Motor (7267.T) is finalising plans to build a dedicated hybrid-vehicle plant in Ohio at a cost of up to ¥400 billion ($2.53 billion), a move that underscores the automaker’s...
Eli Lilly (LLY.N) signed a research collaboration and licensing pact with Beijing-based InnoCare Pharma (688428.SS) worth up to $3.35 billion on Thursday, underscoring Big Pharma’s...
Airport workers at Qantas Airways (QAN.AX) walked off the job Thursday across Sydney, Brisbane, Adelaide and Perth in a 24-hour strike over pay, job security and safety, adding...
Roche (ROG.S) said Monday its experimental drug enicepatide meaningfully cut blood-sugar levels and body weight in a clinical trial, sharpening the Swiss drugmaker’s competitive...
